What are the treatment options for cluster headaches?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Cluster Headaches

High-flow oxygen therapy (12-15 L/min via non-rebreather mask for 15 minutes) and subcutaneous sumatriptan (6 mg) are the first-line treatments for acute cluster headache attacks. 1

Acute Treatment Options

First-Line Treatments

  • High-flow oxygen therapy (12-15 L/min)

    • Provides relief in a significant proportion of patients
    • Should be administered via non-rebreather mask for 15 minutes
    • Clinical trials show 78% of patients achieve pain freedom at 15 minutes compared to 20% with placebo 2
    • Patients should be educated to begin treatment immediately at attack onset for maximum effectiveness
  • Subcutaneous sumatriptan (6 mg)

    • Provides relief within 10-15 minutes in 49-74% of patients
    • FDA-approved specifically for cluster headache 3
    • Clinical trials show 49% of patients achieve pain relief at 10 minutes and 74% at 15 minutes 3
    • Contraindicated in patients with cardiovascular disease
    • Should be readily available during cluster periods

Alternative Acute Treatments

  • Intranasal zolmitriptan (10 mg)
    • Alternative when sumatriptan is contraindicated
    • 62% of patients achieve pain relief at 30 minutes compared to 26% with placebo 4

Preventive Treatment Options

First-Line Preventive Treatments

  • Verapamil (minimum 240 mg daily)

    • First-line preventive therapy for chronic cluster headache
    • Requires ECG monitoring before initiation and with dose increases
    • Maximum dose depends on efficacy and tolerability 5
  • Galcanezumab (monoclonal antibody to CGRP)

    • Recommended for episodic cluster headache prevention
    • Not recommended for chronic cluster headache 1

Bridging Therapies

  • Corticosteroids
    • Used as short-term bridging therapy until preventive medications take effect
    • At least 100 mg prednisone orally or up to 500 mg IV daily for 5 days 1, 5
    • Not suitable for long-term use due to side effects

Additional Preventive Options

  • Non-invasive vagus nerve stimulation

    • Recommended for episodic cluster headache
    • Not effective for chronic cluster headache 1, 6
    • Parameters of stimulation (intensity, frequency, duration) are critical for effectiveness
  • Alternative preventives when first-line treatments fail:

    • Lithium
    • Topiramate
    • Greater occipital nerve blocks 1, 5

Important Clinical Considerations

Treatment Pitfalls to Avoid

  • Avoid opioids for cluster headache treatment due to risk of dependency and rebound headaches 1
  • Monitor for medication overuse headache (headache occurring on 15+ days per month for at least 3 months)
  • Avoid treatment delays - educate patients to begin treatment immediately at attack onset
  • Cardiac monitoring is necessary for patients on verapamil (ECG before initiation and with dose increases)

Patient Education

  • Counsel patients to avoid triggers, particularly alcohol
  • Arrange home oxygen with provision for urgent 4-hour installation when a cluster period begins
  • Oxygen concentrators can be an effective alternative to oxygen tanks
  • Patients with cardiac conditions should consult healthcare professionals before starting vagus nerve stimulation

Regular evaluation of treatment efficacy is necessary to adjust therapy based on individual response and tolerability.

References

Guideline

Acute Cluster Headache Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Triptans for acute cluster headache.

The Cochrane database of systematic reviews, 2010

Research

Management of cluster headache: Treatments and their mechanisms.

Cephalalgia : an international journal of headache, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.